Related Experiment Video
Updated: May 14, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Causal Effects of Female Reproductive and Hormonal Factors on Osteoporosis, Bone Mineral Density, and Osteoarthritis:
Guangjun Li1, Wen Shen2, Jian Chen3
1Department of Orthopedics, Deqing People's Hospital, Deqing, Zhejiang, 313200, People's Republic of China.
Purpose:
The causal links between female reproductive and hormonal factors and bone diseases remain uncertain, partly due to conflicting observational evidence and potential reverse causation. We used two-sample Mendelian randomization (MR) to clarify these relationships.
Methods:
Using large-scale genome-wide association studies (GWAS), predominantly from individuals of European ancestry, we analyzed 12 reproductive and hormonal exposures, including reproductive milestones, fertility history, and hormonal interventions, against 7 bone-related outcomes. Genetically predicted causal effects were estimated using inverse-variance weighted (IVW) MR after removing pleiotropic outliers via the MR-PRESSO test. Heterogeneity and pleiotropy were assessed using MR-Egger, Steiger directionality, and leave-one-out analyses.
Results:
After FDR correction (FDR < 0.05), genetically predicted effects showed that later age at menarche was associated with higher osteoporosis risk (OR: 1.59) and lower bone mineral density (BMD) (OR: 0.88), whereas later age at menopause was associated with reduced osteoporosis risk (OR: 0.74) and, after outlier removal, higher BMD in women aged 45-60 years (OR: 1.17). Ever use of hormone replacement therapy was also associated with higher mid-life BMD in women aged after outlier correction (OR: 0.71). Longer menstrual cycles were associated with lower BMD (OR: 0.83), and later age at last oral contraceptives (OCP) use showed a modest association with lower BMD (OR: 0.65). Regarding osteoarthritis, later age at first and last live birth was associated with lower risk (OR: 0.81 and 0.75, respectively), and later age at starting OCP was associated with reduced osteoarthritis risk (OR: 0.88).
Conclusion:
This study provides genetic evidence for the protective role of a longer reproductive lifespan on bone health. Hormonal factors exert distinct causal effects on osteoporosis and osteoarthritis, which is critical for informing targeted prevention strategies.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bone Remodeling
Disorders of the Female Reproductive System
Oogenesis
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...